Paul Wren

1.8k total citations · 1 hit paper
19 papers, 1.2k citations indexed

About

Paul Wren is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Paul Wren has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Paul Wren's work include Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Receptor Mechanisms and Signaling (3 papers) and Neuropeptides and Animal Physiology (3 papers). Paul Wren is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Receptor Mechanisms and Signaling (3 papers) and Neuropeptides and Animal Physiology (3 papers). Paul Wren collaborates with scholars based in United Kingdom, United States and Italy. Paul Wren's co-authors include Xiao-Ming Guan, Pradeep J. Nathan, Guhan Nagappan, Bai Lu, Alan Thorpe, Hanne Duve, Margaret Wood, Yanhua Zhang, Douglas S. Johnson and Cory M. Stiff and has published in prestigious journals such as Neuron, Nature reviews. Neuroscience and Neuroscience.

In The Last Decade

Paul Wren

19 papers receiving 1.1k citations

Hit Papers

BDNF-based synaptic repair as a disease-modifying strateg... 2013 2026 2017 2021 2013 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Wren United Kingdom 13 505 333 274 260 151 19 1.2k
Arnauld Belmer Australia 21 626 1.2× 404 1.2× 178 0.6× 135 0.5× 90 0.6× 47 1.3k
Anne Quiedeville France 9 394 0.8× 334 1.0× 276 1.0× 122 0.5× 125 0.8× 10 1.2k
Matthew R. Skelton United States 30 731 1.4× 388 1.2× 358 1.3× 199 0.8× 85 0.6× 70 2.1k
Magdalena Miranda Argentina 10 383 0.8× 280 0.8× 250 0.9× 83 0.3× 171 1.1× 23 1.2k
Liming Zhang China 21 366 0.7× 366 1.1× 192 0.7× 193 0.7× 134 0.9× 64 1.4k
Pablo Muñoz Chile 20 375 0.7× 401 1.2× 326 1.2× 87 0.3× 62 0.4× 40 1.2k
Elena Dale United States 16 365 0.7× 295 0.9× 188 0.7× 271 1.0× 69 0.5× 21 1.1k
Ludmyla Kandratavicius Brazil 19 709 1.4× 288 0.9× 112 0.4× 151 0.6× 85 0.6× 36 1.2k

Countries citing papers authored by Paul Wren

Since Specialization
Citations

This map shows the geographic impact of Paul Wren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Wren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Wren more than expected).

Fields of papers citing papers by Paul Wren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Wren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Wren. The network helps show where Paul Wren may publish in the future.

Co-authorship network of co-authors of Paul Wren

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Wren. A scholar is included among the top collaborators of Paul Wren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Wren. Paul Wren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
González-Hunt, Claudia P., Paul Wren, Carrolee Barlow, et al.. (2024). G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage. npj Parkinson s Disease. 10(1). 49–49. 11 indexed citations
2.
Bzdok, Danilo, et al.. (2024). Data science opportunities of large language models for neuroscience and biomedicine. Neuron. 112(5). 698–717. 20 indexed citations
3.
Calsolaro, Valeria, Rainer Hinz, Joseph Nowell, et al.. (2022). Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals. Molecular Psychiatry. 27(4). 2019–2029. 25 indexed citations
4.
Bright, Jessica, et al.. (2021). Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor. Movement Disorders. 36(6). 1362–1371. 14 indexed citations
5.
Robin, Gaëlle, J. C. Evans, David N. Hauser, Paul Wren, & Andreas Zembrzycki. (2020). Longitudinal Characterization of Transcriptomic, Functional, and Morphological Features in Human iPSC-Derived Neurons and Their Application to Investigate Translational Progranulin Disease Biology. Frontiers in Aging Neuroscience. 12. 576678–576678. 5 indexed citations
6.
Yang, Ting, Xichen Lin, Qian Ding, et al.. (2018). Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists. Journal of Medicinal Chemistry. 61(6). 2518–2532. 16 indexed citations
7.
Yang, Ting, Paul Wren, Yueting Zhang, et al.. (2014). 2-Aminopyrimidin-4(1H)-one as the novel bioisostere of urea: Discovery of novel and potent CXCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 24(23). 5493–5496. 11 indexed citations
8.
Rutter, A. Richard, Jessica L. Schneck, Dino Montanari, et al.. (2014). GSK356278, a Potent, Selective, Brain-Penetrant Phosphodiesterase 4 Inhibitor That Demonstrates Anxiolytic and Cognition-Enhancing Effects without Inducing Side Effects in Preclinical Species. Journal of Pharmacology and Experimental Therapeutics. 350(1). 153–163. 42 indexed citations
9.
Barnes, Nicholas M., et al.. (2013). p38 MAP kinase activation does not stimulate serotonin transport in rat brain: Implications for sickness behaviour mechanisms. Life Sciences. 93(1). 30–37. 12 indexed citations
10.
Lu, Bai, Guhan Nagappan, Xiao-Ming Guan, Pradeep J. Nathan, & Paul Wren. (2013). BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nature reviews. Neuroscience. 14(6). 401–416. 601 indexed citations breakdown →
11.
Ahn, Kay, Sarah E. Smith, Marya Liimatta, et al.. (2011). Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain. Journal of Pharmacology and Experimental Therapeutics. 338(1). 114–124. 191 indexed citations
13.
Wood, Margaret & Paul Wren. (2008). Serotonin–dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders. Progress in brain research. 172. 213–230. 36 indexed citations
14.
Scott, Claire M., Ellen M. Soffin, Matthew Hill, et al.. (2006). SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue. European Journal of Pharmacology. 536(1-2). 54–61. 13 indexed citations
15.
Palin, Ronald, John K. Clark, Jean E. Cottney, et al.. (2004). Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 589–593. 10 indexed citations
16.
Loder, Merewyn K., Shanwei Shen, Paul Wren, et al.. (2000). The production and analysis of transgenic mice expressing the human serotonin transporter.. European Journal of Neuroscience. 12. 173–173. 2 indexed citations
17.
Nicholas, Richard, et al.. (1999). Peripheral inflammation increases the capsaicin sensitivity of dorsal root ganglion neurons in a nerve growth factor-dependent manner. Neuroscience. 91(4). 1425–1433. 43 indexed citations
18.
Wren, Paul, et al.. (1997). Preventing the spread of AIDS in youth: Principles of practice from 11 diverse projects. Journal of Adolescent Health. 21(5). 309–317. 20 indexed citations
19.
Duve, Hanne, Paul Wren, & Alan Thorpe. (1995). Innervation of the foregut of the cockroach Leucophaea maderae and inhibition of spontaneous contractile activity by callatostatin neuropeptides. Physiological Entomology. 20(1). 33–44. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026